mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.1 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |